Literature DB >> 23333248

ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma.

Sezgin Gunes1, Yurdanur Sullu, Zeynep Yegin, Recep Buyukalpelli, Leman Tomak, Hasan Bagci.   

Abstract

ErbB receptor tyrosine kinases family plays an important role in cell cycle regulation. Overexpression of ErbB receptors has been described in several solid tumors. The aim of this study was to investigate the levels of ErbB1, ErbB2, ErbB3, and ErbB4 expression in bladder cancer. Urinary bladder tumor samples were obtained from 33 bladder cancers and 7 non-cancerous bladder biopsies. The levels of ErbB1, ErbB2, ErbB3, and ErbB4 genes expression in bladder cancer were determined by real-time PCR. The presence of protein was confirmed by immunostaining. Expression of ErbB1, ErbB2, ErbB3, and ErbB4 genes increased 0.67, 4.72, 2.89, and 2.65-fold, respectively, in bladder tumors as compared with normal tissue. There was a significant difference between immunostaining results of ErbB4 protein in bladder tumors and normal bladder tissue (P<0.01). The present data suggest that ErbB2, ErbB3, and ErbB4 genes may have a role in bladder cancer tumorigenesis.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23333248     DOI: 10.1016/j.prp.2012.10.014

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

1.  Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

Authors:  Michela de Martino; Dazhong Zhuang; Tobias Klatte; Malte Rieken; Morgan Rouprêt; Evanguelos Xylinas; Thomas Clozel; Martin Krzywinski; Olivier Elemento; Shahrokh F Shariat
Journal:  Cancer Biol Ther       Date:  2014-07-14       Impact factor: 4.742

2.  Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer.

Authors:  Chun Jye Lim; Phuong Hoang Diem Nguyen; Martin Wasser; Pavanish Kumar; Yun Hua Lee; Nurul Jannah Mohamed Nasir; Camillus Chua; Liyun Lai; Sharifah Nur Hazirah; Josh Jie Hua Loh; Li Yan Khor; Joe Yeong; Tony Kiat Hon Lim; Alvin Wei Xiang Low; Salvatore Albani; Tsung Wen Chong; Valerie Chew
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

3.  Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer.

Authors:  Damian Kołat; Żaneta Kałuzińska; Elżbieta Płuciennik
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 4.  Role of tyrosine kinases in bladder cancer progression: an overview.

Authors:  Amir Sadra Zangouei; Amir Hossein Barjasteh; Hamid Reza Rahimi; Majid Mojarrad; Meysam Moghbeli
Journal:  Cell Commun Signal       Date:  2020-08-14       Impact factor: 5.712

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.